# Interferon Toxicities in Melanoma Treatment

> **NCT02794636** · — · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 436 (actual)

## Conditions studied

- Stage III Melanoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02794636
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2016-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02794636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02794636, "Interferon Toxicities in Melanoma Treatment". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02794636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*